Norway· NO-ID_98504906-34F0-44A7-870B-E4ABA2296A92
Kardegic
A acetylsalicylic acid product containing d,l-lysine acetylsalicylate, registered in Norway by Sanofi-Aventis France. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Acetylsalicylic acid is registered in 14 of 19 countries.
Countries holding a registration under ATC B01AC06 (acetylsalicylic acid), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Acetylsalicylic acid · ATC B01AC06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- D,l-Lysine Acetylsalicylate
- Manufacturer
- Sanofi-Aventis France
- Country
- Norway (NO)
- ATC code
- B01AC06
- ATC class
- Acetylsalicylic acid
- Defined daily dose
- 1 Tablette, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_98504906-34F0-44A7-870B-E4ABA2296A92
- no_varenummer29387230
- gtin3400933226558
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
836 interactions on record for acetylsalicylic acid.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acetylsalicylic acid · interactions on record
836 records
- 55 severe
- 246 moderate
- 39 minor
- 429 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AC06
Acetylsalicylic acid, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1d59071-cab6-4a14-846c-de0da4f25e0b GET /v1/drugs/b1d59071-cab6-4a14-846c-de0da4f25e0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til mikstur, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Acetylsalisylsyre",
"merkevare_id": "ID_98504906-34F0-44A7-870B-E4ABA2296A92",
"name_form_strength": "Kardegic pulv til mikst, oppl 300 mg/dose",
"prescription_group": "C"
}See everything about acetylsalicylic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.